TP53 and cancer: It is however worth noting that TP53 mutations are early events in the progression from esophageal dysplasia to cancer [31]; therefore, the early identification of specific types of variants, i.e., damaging amino acid substitutions, might be of critical importance, especially from the perspective of selecting the most efficient approach for targeted therapies.